Aggrenox Antitrust Litigation Class Action Class Action Lawsuit Settlement

Aggrenox Antitrust Litigation Class Action Class Action Lawsuit Settlement

Claim Deadline Reached!

Who Qualifies

You are a Consumer Class Member if you: • Purchased and/or paid for Aggrenox® or generic versions of Aggrenox®, • In the Commonwealth of Puerto Rico, Arizona, California, Colorado, District of Columbia, Florida, Hawaii, Illinois, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon (2010 or after), Rhode Island (purchases after July 15, 2013), South Dakota, Tennessee, Utah, Vermont, West Virginia, and Wisconsin • For consumption by yourself or your family, • From November 30, 2009 through December 22, 2017.



About How Much Money

Varies




What Proof is Needed

None






Case Information

In re: Aggrenox® Antitrust Litigation, Case No. 3:14-md-02516-SRU District Court for the District of Connecticut



Case Description

The lawsuit claims that Defendants Boehringer Ingelheim and Teva Pharmaceutical hurt competition and violated state laws by delaying the availability of allegedly less-expensive generic versions of Aggrenox®. Defendants deny any wrongdoing.



Amount Available for Settlement

$54,000,000.00





Fill out Form Before

09/14/2018



Settlement Contact Information

Aggrenox Settlement
c/o A.B. Data, Ltd.
P.O. Box 173046
Milwaukee, WI 53217
P:800-494-2165
info@InReAggrenoxAntitrustLitigation.com